Traumatic brain injury (TBI) remains a serious health concern, and TBI is one of the leading
causes of death and disability, especially among young adults. Although preventive …

Traumatic brain injury (TBI) is one of the leading causes of death and disability around the
world. The lack of validated biomarkers for TBI is a major impediment to developing effective …

Rapid triage and decision‐making in the treatment of traumatic brain injury (TBI) present
challenging dilemma in “resource poor” environments such as the battlefield and developing …

During the past decade there has been an increasing recognition of the incidence of mild
traumatic brain injury (mTBI) and a better understanding of the subtle neurological and …

Background We aimed to understand the relationship between serum biomarker
concentration and lesion type and volume found on computed tomography (CT) following all …

Over the last decade, biomarker research has identified potential biomarkers for the
diagnosis, prognosis, and management of traumatic brain injury (TBI). Several cerebrospinal …

BACKGROUND Early identification of traumatic intracranial hemorrhage (ICH) has
implications for triage and intervention. Blood-based biomarkers were recently approved by …

The relationship between systemic inflammation and secondary injury in traumatic brain
injury (TBI) is complex. We investigated associations between inflammatory markers and …

Importance Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-
L1) have been widely studied and show promise for clinical usefulness in suspected …

Mild traumatic brain injury (TBI), which is defined as a head trauma resulting in a brief loss of
consciousness and/or alteration of mental state, is usually benign, but occasionally causes …